135 related articles for article (PubMed ID: 1781423)
1. The regulation of connective tissue metalloproteinases by natural inhibitors.
Murphy G
Agents Actions Suppl; 1991; 35():69-76. PubMed ID: 1781423
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.
Takagi M; Santavirta S; Ida H; Ishii M; Mandelin J; Konttinen YT
Clin Orthop Relat Res; 1998 Jul; (352):35-45. PubMed ID: 9678031
[TBL] [Abstract][Full Text] [Related]
3. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins.
Docherty AJ; Murphy G
Ann Rheum Dis; 1990 Jun; 49 Suppl 1():469-79. PubMed ID: 2197998
[TBL] [Abstract][Full Text] [Related]
4. A metalloproteinase inhibitor as an inhibitor of neovascularization.
Moses MA; Langer R
J Cell Biochem; 1991 Nov; 47(3):230-5. PubMed ID: 1724245
[TBL] [Abstract][Full Text] [Related]
5. [Basic metalloproteinases of the connective tissue matrix].
Solov'eva NI
Bioorg Khim; 1994 Feb; 20(2):143-52. PubMed ID: 8155077
[TBL] [Abstract][Full Text] [Related]
6. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
[No Abstract] [Full Text] [Related]
7. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
Ray JM; Stetler-Stevenson WG
Eur Respir J; 1994 Nov; 7(11):2062-72. PubMed ID: 7533104
[TBL] [Abstract][Full Text] [Related]
8. The matrix-degrading metalloproteinases.
Matrisian LM
Bioessays; 1992 Jul; 14(7):455-63. PubMed ID: 1445287
[TBL] [Abstract][Full Text] [Related]
9. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
Reynolds JJ; Meikle MC
J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF
FASEB J; 1991 May; 5(8):2145-54. PubMed ID: 1850705
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.
Khokha R; Denhardt DT
Invasion Metastasis; 1989; 9(6):391-405. PubMed ID: 2689386
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibition in periodontal treatment.
Ryan ME; Ramamurthy S; Golub LM
Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez DE; Alonso DF; Yoshiji H; Thorgeirsson UP
Eur J Cell Biol; 1997 Oct; 74(2):111-22. PubMed ID: 9352216
[TBL] [Abstract][Full Text] [Related]
15. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of production and action of tissue metalloproteinases.
Reynolds JJ
Ann Biol Clin (Paris); 1986; 44(2):188-94. PubMed ID: 3530063
[TBL] [Abstract][Full Text] [Related]
17. Proteinases in rheumatoid arthritis.
Murphy G; Hembry RM
J Rheumatol Suppl; 1992 Jan; 32():61-4. PubMed ID: 1613735
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG
Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
Hanglow AC; Lugo A; Walsky R; Visnick M; Coffey JW; Fotouhi N
Biochem Biophys Res Commun; 1994 Dec; 205(2):1156-63. PubMed ID: 7802645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
